About this Journal Submit a Manuscript Table of Contents
Sarcoma
Volume 2012 (2012), Article ID 820254, 12 pages
http://dx.doi.org/10.1155/2012/820254
Research Article

Putative Multifunctional Signature of Lung Metastases in Dedifferentiated Chondrosarcoma

1Cancer Biology and Epigenomics Program, Children’s Memorial Research Center, and Department of Pediatrics, Northwestern University Feinberg School of Medicine, 2430 N. Halstead Street, Chicago, IL 60614, USA
2GeneGo, Inc., 500 Renaissance Drive, No. 106, St. Joseph, MI 49085, USA
3Department of Pathology and Laboratory Medicine, Children’s Memorial Hospital 2300 Children’s Plaza, Chicago, IL 60614, USA
4Center for Bioinformatics and Computation Biology, University of Iowa, 5316 Seamans Center, Iowa City, IA 52242, USA
5Department of Orthopaedics and Rehabilitation, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA
6Vavilov Institute for General Genetics, Russian Academy of Sciences, 3 Gubkina Street, Moscow 117093, Russia
7Department of Urology, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA
8Department of Hematology/Oncology, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA
9Department of Surgical Pathology, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA
10Lung Cancer and Thoracic Oncology Program, Beckman Research Institute, City of Hope, 1500 East Duarte Road, Duarte, CA 91010, USA
11Department of Pediatrics, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA

Received 12 May 2011; Revised 21 October 2011; Accepted 3 November 2011

Academic Editor: Alessandro Gronchi

Copyright © 2012 Sergey Malchenko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Littrell, D. E. Wenger, L. E. Wold et al., “Radiographic, CT, and MR imaging features of dedifferentiated chondrosarcomas: a retrospective review of 174 De Novo cases,” Radiographics, vol. 24, no. 5, pp. 1397–1409, 2004. View at Scopus
  2. I. D. Dickey, P. S. Rose, B. Fuchs et al., “Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes,” Journal of Bone and Joint Surgery—Series A, vol. 86, no. 11, pp. 2412–2418, 2004. View at Scopus
  3. P. F. M. Choong and A. P. W. Nadesapillai, “Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis,” Clinical Orthopaedics and Related Research, no. 415, pp. S46–S58, 2003. View at Scopus
  4. J. V. M. G. Bovée, P. C. W. Hogendoorn, J. S. Wunder, and B. A. Alman, “Cartilage tumours and bone development: molecular pathology and possible therapeutic targets,” Nature Reviews Cancer, vol. 10, no. 7, pp. 481–488, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. J. Tolar, A. J. Nauta, M. J. Osborn et al., “Sarcoma derived from cultured mesenchymal stem cells,” Stem Cells, vol. 25, no. 2, pp. 371–379, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. A. B. Mohseny, K. Szuhai, S. Romeo et al., “Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2,” Journal of Pathology, vol. 219, no. 3, pp. 294–305, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. A. B. Mohseny and P. C. W. Hogendoorn, “Concise review: mesenchymal tumors: when stem cells go mad,” Stem Cells, vol. 29, no. 3, pp. 397–403, 2011. View at Publisher · View at Google Scholar · View at PubMed
  8. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. E. A. Seftor, P. S. Meltzer, D. A. Kirschmann et al., “Molecular determinants of human uveal melanoma invasion and metastasis,” Clinical and Experimental Metastasis, vol. 19, no. 3, pp. 233–246, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. De Fatima Bonaldo, G. Lennon, and M. B. Soares, “Normalization and subtraction: two approaches to facilitate gene discovery,” Genome Research, vol. 6, no. 9, pp. 791–806, 1996. View at Scopus
  11. V. E. Velculescu, L. Zhang, B. Vogelstein, and K. W. Kinzler, “Serial analysis of gene expression,” Science, vol. 270, no. 5235, pp. 484–487, 1995. View at Scopus
  12. K. Boon, E. C. Osório, S. F. Greenhut et al., “An anatomy of normal and malignant gene expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 17, pp. 11287–11292, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. M. Z. Man, X. Wang, and Y. Wang, “POWER_SAGE: comparing statistical tests for SAGE experiments,” Bioinformatics, vol. 16, no. 11, pp. 953–959, 2000. View at Scopus
  14. Y. Nikolsky, E. Kirillov, R. Zuev, E. Rakhmatulin, and T. Nikolskaya, “Functional analysis of OMICs data and small molecule compounds in an integrated “knowledge-based” platform,” Methods in Molecular Biology, vol. 563, pp. 177–196, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. B. Eisen, P. T. Spellman, P. O. Brown, and D. Botstein, “Cluster analysis and display of genome-wide expression patterns,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14863–14868, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Gijsbers, M. Gouwy, S. Struyf et al., “GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors,” Experimental Cell Research, vol. 303, no. 2, pp. 331–342, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. D. F. Smith, E. Galkina, K. Ley, and Y. Huo, “GRO family chemokines are specialized for monocyte arrest from flow,” American Journal of Physiology, vol. 289, no. 5, pp. H1976–H1984, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. M. Resnati, M. Guttinger, S. Valcamonica, N. Sidenius, F. Blasi, and F. Fazioli, “Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect,” The EMBO Journal, vol. 15, no. 7, pp. 1572–1582, 1996. View at Scopus
  19. G. F. Weber and S. Ashkar, “Molecular mechanisms of tumor dissemination in primary and metastatic brain cancers,” Brain Research Bulletin, vol. 53, no. 4, pp. 421–424, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Bingle, N. J. Brown, and C. E. Lewis, “The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies,” Journal of Pathology, vol. 196, no. 3, pp. 254–265, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. M. Van Dongen, N. D. L. Savage, E. S. Jordanova et al., “Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumors,” International Journal of Cancer, vol. 127, no. 4, pp. 899–909, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. T. Fujiwara, J.-I. Fukushi, S. Yamamoto et al., “Macrophage infiltration predicts a poor prognosis for human ewing sarcoma,” American Journal of Pathology, vol. 179, no. 3, pp. 1157–1170, 2011. View at Publisher · View at Google Scholar · View at PubMed
  23. J. W. Pollard, “Tumour-educated macrophages promote tumour progression and metastasis,” Nature Reviews Cancer, vol. 4, no. 1, pp. 71–78, 2004. View at Scopus
  24. R. B. Jakobsen, A. Shahdadfar, F. P. Reinholt, and J. E. Brinchmann, “Chondrogenesis in a hyaluronic acid scaffold: comparison between chondrocytes and MSC from bone marrow and adipose tissue,” Knee Surgery, Sports Traumatology, Arthroscopy, vol. 18, no. 10, pp. 1407–1416, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. J. T. Hecht and E. H. Sage, “Retention of the matricellular protein SPARC in the endoplasmic reticulum of chondrocytes from patients with pseudoachondroplasia,” Journal of Histochemistry and Cytochemistry, vol. 54, no. 3, pp. 269–274, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. T. Dehne, C. Karlsson, J. Ringe, M. Sittinger, and A. Lindahl, “Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte transplantation,” Arthritis Research & Therapy, vol. 11, no. 5, article R133, 2009.
  27. M. C. Embree, T. M. Kilts, M. Ono et al., “Biglycan and fibromodulin have essential roles in regulating chondrogenesis and extracellular matrix turnover in temporomandibular joint osteoarthritis,” American Journal of Pathology, vol. 176, no. 2, pp. 812–826, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. L. B. Rozeman, L. Hameetman, T. van Wezel et al., “cDNA expression profiling of chondrosarcomas: ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade,” Journal of Pathology, vol. 207, no. 1, pp. 61–71, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. T. Sun, E. B. Hunziker, and T. I. Morales, “Subcellular distribution of the insulin-like growth factor (IGF) binding proteins (IGFBPs) 2 and 3 in articular chondrocytes,” Journal of Orthopaedic Research, vol. 26, no. 11, pp. 1421–1427, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. S. P. Grogan, A. Barbero, J. Diaz-Romero et al., “Identification of markers to characterize and sort human articular chondrocytes with enhanced in vitro chondrogenic capacity,” Arthritis and Rheumatism, vol. 56, no. 2, pp. 586–595, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. D. L. Cecil and R. Terkeltaub, “Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes,” Journal of Immunology, vol. 180, no. 12, pp. 8378–8385, 2008. View at Scopus
  32. J. Kruegel, B. Sadowski, and N. Miosge, “Nidogen-1 and nidogen-2 in healthy human cartilage and in late-stage osteoarthritis cartilage,” Arthritis and Rheumatism, vol. 58, no. 5, pp. 1422–1432, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. R. Morello and F. Rauch, “Role of cartilage-associated protein in skeletal development,” Current Osteoporosis Reports, vol. 8, no. 2, pp. 77–83, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. A. Gomez-Brouchet, F. Mourcin, P. A. Gourraud et al., “Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma,” Human Pathology, vol. 41, no. 9, pp. 1220–1230, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. X. Tang, X. Lu, W. Guo et al., “Different expression of Sox9 and Runx2 between chondrosarcoma and dedifferentiated chondrosarcoma cell line,” European Journal of Cancer Prevention, vol. 19, no. 6, pp. 466–471, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. K. H. Hallor, J. Staaf, J. V. M. G. Bové et al., “Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors,” Clinical Cancer Research, vol. 15, no. 8, pp. 2685–2694, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. S. Söder, A. M. Oliveira, C. Y. Inwards, S. Müller, and T. Aigner, “Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma,” Pathology, vol. 38, no. 1, pp. 35–38, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. L. Huang, Y. Y. Cheng, L. T. C. Chow, M. H. Zheng, and S. M. Kumta, “Receptor activator of NF-κB ligand (RANKL) is expressed in chondroblastoma: possible involvement in osteoclastic giant cell recruitment,” Journal of Clinical Pathology, vol. 56, no. 2, pp. 116–120, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. C. G. Hackel, S. Krueger, and H. J. Grote Grote, “Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma,” Cancer, vol. 89, no. 5, pp. 995–1003, 2000. View at Publisher · View at Google Scholar
  40. C. Häckel, B. Czerniak, A. G. Ayala, K. Radig, and A. Roessner, “Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma,” Cancer, vol. 79, no. 1, pp. 53–58, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Koide, A. Nishio, T. Sato, A. Sugiyama, and S. I. Miyagawa, “Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus,” American Journal of Gastroenterology, vol. 99, no. 9, pp. 1667–1674, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. A. S. Payne and L. A. Cornelius, “The role of chemokines in melanoma tumor growth and metastasis,” Journal of Investigative Dermatology, vol. 118, no. 6, pp. 915–922, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. J. D. Hood and D. A. Cheresh, “Role of integrins in cell invasion and migration,” Nature Reviews Cancer, vol. 2, no. 2, pp. 91–100, 2002. View at Scopus
  44. A. Calvo, R. Catena, M. S. Noble et al., “Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis,” Oncogene, vol. 27, no. 40, pp. 5373–5384, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. M. Gulubova and T. Vlaykova, “Immunohistochemical assessment of fibronectin and tenascin and their integrin receptors α5β1 and α9β1 in gastric and colorectal cancers with lymph node and liver metastases,” Acta Histochemica, vol. 108, no. 1, pp. 25–35, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. L. A. Carver and J. E. Schnitzer, “Caveolae: mining little caves for new cancer targets,” Nature Reviews Cancer, vol. 3, no. 8, pp. 571–581, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. T. M. Williams and M. P. Lisanti, “Caveolin-1 in oncogenic transformation, cancer, and metastasis,” American Journal of Physiology, vol. 288, no. 3, pp. C494–C506, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. E. Hiendlmeyer, S. Regus, S. Wassermann et al., “Beta-catenin up-regulates the expression of the urokinase plasminogen activator in human colorectal tumors,” Cancer Research, vol. 64, no. 4, pp. 1209–1214, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. J. R. Graff, J. A. Deddens, B. W. Konicek et al., “Integrin-linked kinase expression increases with prostate tumor grade,” Clinical Cancer Research, vol. 7, no. 7, pp. 1987–1991, 2001. View at Scopus
  50. S. Jothy, “CD44 and its partners in metastasis,” Clinical and Experimental Metastasis, vol. 20, no. 3, pp. 195–201, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Kobayashi, M. Suzuki, N. Kanayama, T. Nishida, M. Takigawa, and T. Terao, “CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells,” International Journal of Cancer, vol. 102, no. 4, pp. 379–389, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. S. K. Akiyama, K. Olden, and M. Yamada, “Fibronectin and integrins in invasion and metastasis,” Cancer and Metastasis Reviews, vol. 14, no. 3, pp. 173–189, 1995. View at Publisher · View at Google Scholar · View at Scopus
  53. A. J. Minn, G. P. Gupta, P. M. Siegel et al., “Genes that mediate breast cancer metastasis to lung,” Nature, vol. 436, no. 7050, pp. 518–524, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. H. Saji, H. Nakamura, I. Awut et al., “Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues,” Annals of Thoracic and Cardiovascular Surgery, vol. 9, no. 5, pp. 295–300, 2003. View at Scopus
  55. B. E. Nicholson, H. F. Frierson, M. R. Conaway et al., “Profiling the evolution of human metastatic bladder cancer,” Cancer Research, vol. 64, no. 21, pp. 7813–7821, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. M. Ishii, C. Koike, A. Igarashi et al., “Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts,” Biochemical and Biophysical Research Communications, vol. 332, no. 1, pp. 297–303, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. M. Honczarenko, Y. Le, M. Swierkowski, I. Ghiran, A. M. Glodek, and L. E. Silberstein, “Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors,” Stem Cells, vol. 24, no. 4, pp. 1030–1041, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. C. D. Li, W. Y. Zhang, H. L. Li et al., “Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation,” Cell Research, vol. 15, no. 7, pp. 539–547, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. J. S. Park, H. Y. Kim, H. W. Kim et al., “Increased caveolin-1, a cause for the declined adipogenic potential of senescent human mesenchymal stem cells,” Mechanisms of Ageing and Development, vol. 126, no. 5, pp. 551–559, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. U. R. Goessler, K. Bieback, P. Bugert et al., “In vitro analysis of integrin expression during chondrogenic differentiation of mesenchymal stem cells and chondrocytes upon dedifferentiation in cell culture,” International Journal of Molecular Medicine, vol. 17, no. 2, pp. 301–307, 2006. View at Scopus
  61. S. Neuss, R. K. M. Schneider, L. Tietze, R. Knüchel, and W. Jahnen-Dechent, “Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots,” Cells Tissues Organs, vol. 191, no. 1, pp. 36–46, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. S. Boeuf, P. Kunz, T. Hennig et al., “A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma,” Journal of Pathology, vol. 216, no. 2, pp. 158–166, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. K. Kudoh, M. Ramanna, R. Ravatn et al., “Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray,” Cancer Research, vol. 60, no. 15, pp. 4161–4166, 2000. View at Scopus
  64. G. S. Watts, B. W. Futscher, R. Isett, M. Gleason-Guzman, M. W. Kunkel, and S. E. Salmon, “cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways,” Journal of Pharmacology and Experimental Therapeutics, vol. 299, no. 2, pp. 434–441, 2001. View at Scopus
  65. E. P. Buddingh, M. L. Kuijjer, R. A. J. Duim et al., “Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents,” Clinical Cancer Research, vol. 17, no. 8, pp. 2110–2119, 2011. View at Publisher · View at Google Scholar · View at PubMed
  66. L. L'Italien, M. Tanudji, L. Russell, and X. M. Schebye, “Unmasking the redundancy between Cdk1 and Cdk2 at G2 phase in human cancer cell lines,” Cell Cycle, vol. 5, no. 9, pp. 984–993, 2006. View at Scopus
  67. R. E. Gerszten, E. A. Garcia-Zepeda, Y. C. Lim et al., “MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions,” Nature, vol. 398, no. 6729, pp. 718–725, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. M. Gouwy, S. Struyf, J. Catusse, P. Proost, and J. Van Damme, “Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration,” Journal of Leukocyte Biology, vol. 76, no. 1, pp. 185–194, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. E. T. A. Fry, D. L. Mack, and B. E. Sobel, “The nature of synergy between tissue-type and single chain urokinase-type plasminogen activators,” Thrombosis and Haemostasis, vol. 62, no. 3, pp. 909–916, 1989. View at Scopus